222 related articles for article (PubMed ID: 19228774)
21. Notch signaling regulates osteosarcoma proliferation and migration through Erk phosphorylation.
Qin J; Wang R; Zhao C; Wen J; Dong H; Wang S; Li Y; Zhao Y; Li J; Yang Y; He X; Wang D
Tissue Cell; 2019 Aug; 59():51-61. PubMed ID: 31383289
[TBL] [Abstract][Full Text] [Related]
22. Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ-secretase inhibitor targeting notch signaling.
Kolb EA; Gorlick R; Keir ST; Maris JM; Lock R; Carol H; Kurmasheva RT; Reynolds CP; Kang MH; Wu J; Houghton PJ; Smith MA
Pediatr Blood Cancer; 2012 May; 58(5):815-8. PubMed ID: 22052798
[TBL] [Abstract][Full Text] [Related]
23. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
[TBL] [Abstract][Full Text] [Related]
25. Characterization of Notch Signaling During Osteogenic Differentiation in Human Osteosarcoma Cell Line MG63.
Ongaro A; Pellati A; Bagheri L; Rizzo P; Caliceti C; Massari L; De Mattei M
J Cell Physiol; 2016 Dec; 231(12):2652-63. PubMed ID: 26946465
[TBL] [Abstract][Full Text] [Related]
26. Notch signaling, gamma-secretase inhibitors, and cancer therapy.
Shih IeM; Wang TL
Cancer Res; 2007 Mar; 67(5):1879-82. PubMed ID: 17332312
[TBL] [Abstract][Full Text] [Related]
27. High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas.
Köchert K; Ullrich K; Kreher S; Aster JC; Kitagawa M; Jöhrens K; Anagnostopoulos I; Jundt F; Lamprecht B; Zimber-Strobl U; Stein H; Janz M; Dörken B; Mathas S
Oncogene; 2011 Apr; 30(15):1831-40. PubMed ID: 21119597
[TBL] [Abstract][Full Text] [Related]
28. Notch-regulation upon Dll4-stimulation of TGFb-induced apoptosis and gene expression in human B-cell non-Hodgkin lymphomas.
Hajdu M; Kopper L; Sebestyén A
Scand J Immunol; 2010 Jan; 71(1):29-37. PubMed ID: 20017807
[TBL] [Abstract][Full Text] [Related]
29. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
30. Notch signaling regulates cell density-dependent apoptosis of NIH 3T3 through an IL-6/STAT3 dependent mechanism.
Matsuno Y; Kiwamoto T; Morishima Y; Ishii Y; Hizawa N; Hogaboam CM
Eur J Cell Biol; 2018 Sep; 97(7):512-522. PubMed ID: 30249464
[TBL] [Abstract][Full Text] [Related]
31. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44
Barat S; Chen X; Cuong Bui K; Bozko P; Götze J; Christgen M; Krech T; Malek NP; Plentz RR
Stem Cells Transl Med; 2017 Mar; 6(3):819-829. PubMed ID: 28186678
[TBL] [Abstract][Full Text] [Related]
32. Ethanol inhibits γ-secretase proteolytic activity in vascular smooth muscle cells.
Hatch E; Morrow D; Liu W; Cahill PA; Redmond EM
Alcohol Clin Exp Res; 2015 Nov; 39(11):2115-22. PubMed ID: 26443551
[TBL] [Abstract][Full Text] [Related]
33. Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer.
Dong Y; Li A; Wang J; Weber JD; Michel LS
Cancer Res; 2010 Jul; 70(13):5465-74. PubMed ID: 20570903
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase.
Li T; Wen H; Brayton C; Das P; Smithson LA; Fauq A; Fan X; Crain BJ; Price DL; Golde TE; Eberhart CG; Wong PC
J Biol Chem; 2007 Nov; 282(44):32264-73. PubMed ID: 17827153
[TBL] [Abstract][Full Text] [Related]
35. NOTCH is part of the transcriptional network regulating cell growth and survival in mouse plasmacytomas.
Shin DM; Shaffer DJ; Wang H; Roopenian DC; Morse HC
Cancer Res; 2008 Nov; 68(22):9202-11. PubMed ID: 19010892
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Notch signaling pathway using γ-secretase inhibitor delivered by a low dose of Triton-X100 in cultured oral cancer cells.
Nasrin A; Hassan M; Ye P
Biochem Biophys Res Commun; 2018 Jan; 495(3):2118-2124. PubMed ID: 29253571
[TBL] [Abstract][Full Text] [Related]
37. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
Wang K; Zhang Q; Li D; Ching K; Zhang C; Zheng X; Ozeck M; Shi S; Li X; Wang H; Rejto P; Christensen J; Olson P
Clin Cancer Res; 2015 Mar; 21(6):1487-96. PubMed ID: 25564152
[TBL] [Abstract][Full Text] [Related]
38. The Notch γ-secretase inhibitor ameliorates kidney fibrosis via inhibition of TGF-β/Smad2/3 signaling pathway activation.
Xiao Z; Zhang J; Peng X; Dong Y; Jia L; Li H; Du J
Int J Biochem Cell Biol; 2014 Oct; 55():65-71. PubMed ID: 25150830
[TBL] [Abstract][Full Text] [Related]
39. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
40. Requirement of Notch activation during regeneration of the intestinal epithelia.
Okamoto R; Tsuchiya K; Nemoto Y; Akiyama J; Nakamura T; Kanai T; Watanabe M
Am J Physiol Gastrointest Liver Physiol; 2009 Jan; 296(1):G23-35. PubMed ID: 19023031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
